P3 Health Partners Inc.
PIII Healthcare Medical Care Facilities
P3 Health Partners Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 2.76% from fiscal 2024. In the quarter to June 2026, revenue grew 8.60%, EPS grew 89.9%, free cash flow fell 272.2% and total debt fell 34.1%, each against the same quarter a year earlier.
Follow PIII
P3 Health Partners Inc. (PIII) EV/Sales
As of 16 October 2026, P3 Health Partners Inc. (PIII) trades at a EV/Sales of 0.1×. Over the past ten years it has ranged from 0.0× (December 2021) to 26.1× (March 2022); the current reading is higher than 16% of that period. That is below the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.2× | 54.21% |
| FY2024 | 0.1× | (24.72%) |
| FY2023 | 0.2× | 3.31% |
| FY2022 | 0.1× | (99.35%) |
| FY2021 | 22.9× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.1× | (55.52%) |
| Mar 2026 | 0.2× | 13.24% |
| Dec 2025 | 0.2× | 5.22% |
| Sep 2025 | 0.2× | 50.62% |
| 18 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| DCGO DocGo Inc. compare | 0.0× |
| PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR compare | 0.0× |
| PIII P3 Health Partners Inc. | 0.1× |
| PARK Park Dental Partners, Inc. compare | 0.3× |
| AIRS AirSculpt Technologies, Inc. compare | 0.8× |
| BTMD biote Corp. compare | 0.8× |
| CCEL Cryo-Cell International Inc. compare | 1.3× |
| JYNT The Joint Corp. compare | 1.4× |
| CCM Concord Medical Services Holdings Limited compare | 2.6× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)